Stella Pharma: We have signed a contract with Edogawa Hospital regarding a specific clinical study, providing our drugs for the research on FDG-PET positive superficial tumors.

JPX · Jul 10 09:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.